Details for Patent: 4,694,007
✉ Email this page to a colleague
Summary for Patent: 4,694,007
Title: | Use of trimetrexate as antiparasitic agent |
Abstract: | A method of treating infections of Toxoplasmosis or P. carini comprising administering to the host an effective amount of trimetrexate, (2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline. |
Inventor(s): | Allegra; Carmen (Vienna, VA), Drake; James C. (Ijamsville, MD), Chabner; Bruce A. (Potomac, MD), Masur; Henry (Bethesda, MD), Kovacs; Joseph A. (Bethesda, MD) |
Assignee: | The United States of America as represented by the Secretary of the (Washington, DC) |
Application Number: | 06/865,055 |
Patent Claim Types: see list of patent claims | Use; Delivery; |
Drugs Protected by US Patent 4,694,007
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |